Skip to Content
April 20, 2023  •  News

Dr. Emily Place to present at TIDES USA event in San Diego

Biologics Consulting is proud to announce that Dr. Emily Place, Senior Consultant at Biologics Consulting, will be presenting at the upcoming TIDES USA Event.

Read More
April 18, 2023  •  Podcast

“Weight of Evidence vs Carcinogenicity Testing (Part 1)” with Bruce Pearce

The ICH has released a new guidance which may allow you to forgo animal carcinogenicity testing in favor of a weight of the evidence argument. We begin our two-part discussion of why this has been added, including the goals of the addendum, on this episode of Insight at Biologics featuring expert Bruce Pearce. And, tune in next time for part 2 to find out how to go about this.

Read More
March 21, 2023  •  Podcast

“Navigating Institutional Memory & Preserving Knowledge” with Kerin Ablashi

In this episode of Insight at Biologics, industry expert Kerin Ablashi delves into institutional memory and knowledge management in the pharmaceutical industry. Discover exactly what institutional memory is, the role it plays in regulatory compliance, operations, and product development, as well as how you can develop knowledge management systems and continuity plans to support your organization, no matter what size.

Read More
March 7, 2023  •  Podcast

“Understanding Cell & Gene Therapy Potency Assay Development” with Diana Colleluori

In this episode of Insight at Biologics, industry expert, Diana Colleluori, explains everything that cell & gene therapy manufacturers need to know about potency assays. Learn about the definition, FDA guidances and regulations, best practices, and how to overcome the hurdles in potency assay development on this episode of Insight at Biologics.

Read More
February 9, 2023  •  Podcast

“How To Maximize Your Product’s Potential with a Regulatory Consulting Group” with HeeSun Smaldore

On this episode of Insight at Biologics, HeeSun Smaldore, Business Unit Lead, shares some helpful thoughts about the intricacies of deciding when to hire an outside consultant.

Read More
January 19, 2023  •  News

Kenneth Guito, COO, named a Top 25 Healthcare Technology Leader of Virginia for 2023

Biologics Consulting Chief Operating Officer Kenneth Guito has been named to The Healthcare Technology Report's Top 25 Healthcare Technology Leaders of Virginia for 2023.

Read More
January 10, 2023  •  Podcast

“Understanding The IND Review Process” with Dr. Emily Place

On this episode of Insight at Biologics, Senior Consultant and industry expert Dr. Emily Noonan Place from Biologics Consulting chats with James Taylor about IND submissions and the review process. The fact is that the regulatory agency doesn't get a lot of time with your IND submission. How, then, does one optimize their IND submission to make the most of the allotted time in the review? And, how do you avoid the most common pitfalls? Find out all of this and more on this episode of Insight at Biologics.

Read More
January 4, 2023  •  Blog

Tips for working with the FDA eStar form

Tips and tricks for navigating the FDA Center for Devices and Radiological Health (CDRH) electronic Submission Template And Resource (eSTAR)

Read More
December 13, 2022  •  Podcast

“FDA Gap Analysis: The What, Why, and How” Featuring David Pepperl

Are you working on a drug or device submission? An FDA gap analysis can actually save you time and money by ensuring your regulatory compliance. David Pepperl explains the importance of performing a gap analysis and more in this episode of Insight at Biologics.

Read More
November 22, 2022  •  Podcast

“What is Ex Vivo Gene Therapy, and What Regulatory Challenges do Developers Face?” Featuring Robert Kutner

Using your own cells to help you heal isn't science fiction anymore. Today, we’re diving deep into the exciting world of ex vivo cell therapy with Robert Kutner of Biologics Consulting, exploring exactly what ex vivo cell therapy is, how it helps fight rare diseases and cancer, and the regulatory disadvantages that producers face.

Read More